Background: Serious mental illness (SMI) reduces life expectancy, primarily due to somatic comorbidity linked to obesity. Meta-analyses have found beneficial effects of lifestyle interventions in people with SMI and recommended their implementation to manage obesity. Objective: The objective of this systematic review was to assess the benefits and harms of individualized lifestyle interventions for weight in people diagnosed with SMI and to explore potential mediators and moderators of the effect. Methods: The protocol was registered at PROSPERO (CRD42016049093). Randomized clinical trials (RCTs) assessing the effect of individualized lifestyle interventions on weight management in people with SMI were included. Primary outcomes were differences in endpoint body mass index (BMI) and the proportion achieving clinically relevant weight loss (≥5%). Secondary outcomes included quality of life, cardiometabolic risk factors, and adverse effects. Results: We included 41 RCTs (n = 4,267). All trials were at high risk of bias according to the Cochrane Handbook for Systematic Reviews of Interventions. The experimental interventions reduced the mean difference in BMI by –0.63 kg/m2 (95% confidence interval [CI] = –1.02 to –0.23; p = 0.002; I2 = 70.7%) compared to the control groups. At postintervention follow-up (17 RCTs), the effect size remained similar but was no longer significant (BMI = –0.63 kg/m2; 95% CI = –1.30 to 0.04; p = 0.07; I2 = 48.8%). The risk ratio for losing ≥5% of baseline weight was 1.51 (95% CI = 1.07–2.13; p = 0.02) compared to the control groups. GRADE showed very low or low quality of evidence. Conclusion: There is a statistically significant, but clinically insignificant, mean effect of individualized lifestyle interventions for weight reduction in people with SMI.

1.
Olfson
M
,
Gerhard
T
,
Huang
C
,
Crystal
S
,
Stroup
TS
.
Premature Mortality Among Adults With Schizophrenia in the United States
.
JAMA Psychiatry
.
2015
Dec
;
72
(
12
):
1172
81
.
[PubMed]
2168-622X
2.
Vancampfort
D
,
Stubbs
B
,
Mitchell
AJ
,
De Hert
M
,
Wampers
M
,
Ward
PB
, et al
Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
.
World Psychiatry
.
2015
Oct
;
14
(
3
):
339
47
.
[PubMed]
1723-8617
3.
DE Hert
M
,
Correll
CU
,
Bobes
J
,
Cetkovich-Bakmas
M
,
Cohen
D
,
Asai
I
, et al
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
.
World Psychiatry
.
2011
Feb
;
10
(
1
):
52
77
.
[PubMed]
1723-8617
4.
Correll
CU
,
Detraux
J
,
De Lepeleire
J
,
De Hert
M
.
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
.
World Psychiatry
.
2015
Jun
;
14
(
2
):
119
36
.
[PubMed]
1723-8617
5.
Vancampfort
D
,
Correll
CU
,
Galling
B
,
Probst
M
,
De Hert
M
,
Ward
PB
, et al
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
.
World Psychiatry
.
2016
Jun
;
15
(
2
):
166
74
.
[PubMed]
1723-8617
6.
Galling
B
,
Roldán
A
,
Nielsen
RE
,
Nielsen
J
,
Gerhard
T
,
Carbon
M
, et al
Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis
.
JAMA Psychiatry
.
2016
Mar
;
73
(
3
):
247
59
.
[PubMed]
2168-622X
7.
Caemmerer
J
,
Correll
CU
,
Maayan
L
.
Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials
.
Schizophr Res
.
2012
Sep
;
140
(
1-3
):
159
68
.
[PubMed]
0920-9964
8.
Bruins
J
,
Jörg
F
,
Bruggeman
R
,
Slooff
C
,
Corpeleijn
E
,
Pijnenborg
M
.
The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis
.
PLoS One
.
2014
Dec
;
9
(
12
):
e112276
.
[PubMed]
1932-6203
9.
Fernández-San-Martín
MI
,
Martín-López
LM
,
Masa-Font
R
,
Olona-Tabueña
N
,
Roman
Y
,
Martin-Royo
J
, et al
The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental disorders: meta-analysis of intervention studies
.
Community Ment Health J
.
2014
Jan
;
50
(
1
):
81
95
.
[PubMed]
0010-3853
10.
Bonfioli
E
,
Berti
L
,
Goss
C
,
Muraro
F
,
Burti
L
.
Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials
.
BMC Psychiatry
.
2012
Jul
;
12
(
1
):
78
.
[PubMed]
1471-244X
11.
Gierisch
JM
,
Nieuwsma
JA
,
Bradford
DW
,
Wilder
CM
,
Mann-Wrobel
MC
,
McBroom
AJ
, et al
Pharmacologic and behavioral interventions to improve cardiovascular risk factors in adults with serious mental illness: a systematic review and meta-analysis
.
J Clin Psychiatry
.
2014
May
;
75
(
5
):
e424
40
.
[PubMed]
0160-6689
12.
Chwastiak
L
.
Making evidence-based lifestyle modification programs available in community mental health centers: why so slow?
J Clin Psychiatry
.
2015
Apr
;
76
(
4
):
e519
20
.
[PubMed]
0160-6689
13.
Kuipers
E
,
Yesufu-Udechuku
A
,
Taylor
C
,
Kendall
T
.
Management of psychosis and schizophrenia in adults: summary of updated NICE guidance
.
BMJ
.
2014
Feb
;
348
feb12 1
:
g1173
.
[PubMed]
0959-8138
14.
Brown
RC
.
Resisting Moralisation in Health Promotion
.
Ethical Theory Moral Pract
.
2018
;
21
(
4
):
997
1011
.
[PubMed]
1386-2820
15.
Thorpe
KE
,
Zwarenstein
M
,
Oxman
AD
,
Treweek
S
,
Furberg
CD
,
Altman
DG
, et al
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers
.
J Clin Epidemiol
.
2009
May
;
62
(
5
):
464
75
.
[PubMed]
0895-4356
16.
Kennedy-Martin
T
,
Curtis
S
,
Faries
D
,
Robinson
S
,
Johnston
J
.
A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results
.
Trials
.
2015
Nov
;
16
(
1
):
495
.
[PubMed]
1745-6215
17.
Crawford
MJ
,
Barnicot
K
,
Patterson
S
,
Gold
C
.
Negative results in phase III trials of complex interventions: cause for concern or just good science?
Vol. 209, The British journal of psychiatry. England;
2016
. p. 6–8.
18.
Ioannidis
JP
.
Adverse events in randomized trials: neglected, restricted, distorted, and silenced.
Vol. 169, Archives of internal medicine. United States;
2009
. p. 1737–9.
19.
Liu
NH
,
Daumit
GL
,
Dua
T
,
Aquila
R
,
Charlson
F
,
Cuijpers
P
, et al
Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas
.
World Psychiatry
.
2017
Feb
;
16
(
1
):
30
40
.
[PubMed]
1723-8617
20.
Higgins
J
,
Green
S.
Cochrane Handbook for Systematic Reviews of intervention.
21.
Speyer
H
,
Christian Brix Nørgaard
H
,
Birk
M
,
Karlsen
M
,
Storch Jakobsen
A
,
Pedersen
K
, et al
The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity
.
World Psychiatry
.
2016
Jun
;
15
(
2
):
155
65
.
[PubMed]
1723-8617
22.
Alphs
LD
,
Bossie
CA
.
ASPECT-R-A Tool to Rate the Pragmatic and Explanatory Characteristics of a Clinical Trial Design
.
Innov Clin Neurosci
.
2016
Feb
;
13
(
1-2
):
15
26
.
[PubMed]
2158-8333
23.
Higgins
JP
,
Altman
DG
,
Gøtzsche
PC
,
Jüni
P
,
Moher
D
,
Oxman
AD
, et al;
Cochrane Bias Methods Group
;
Cochrane Statistical Methods Group
.
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
.
BMJ
.
2011
Oct
;
343
oct18 2
:
d5928
.
[PubMed]
0959-8138
24.
DerSimonian
R
,
Kacker
R
.
Random-effects model for meta-analysis of clinical trials: an update
.
Contemp Clin Trials
.
2007
Feb
;
28
(
2
):
105
14
.
[PubMed]
1551-7144
25.
DerSimonian
R
,
Laird
N
.
Meta-analysis in clinical trials
.
Control Clin Trials
.
1986
Sep
;
7
(
3
):
177
88
.
[PubMed]
0197-2456
26.
Higgins
JP
,
Thompson
SG
,
Deeks
JJ
,
Altman
DG
.
Measuring inconsistency in meta-analyses
.
BMJ
.
2003
Sep
;
327
(
7414
):
557
60
.
[PubMed]
0959-8138
27.
Jakobsen
JC
,
Wetterslev
J
,
Winkel
P
,
Lange
T
,
Gluud
C
.
Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods
.
BMC Med Res Methodol
.
2014
Nov
;
14
(
1
):
120
.
[PubMed]
1471-2288
28.
Wetterslev
J
,
Thorlund
K
,
Brok
J
,
Gluud
C
.
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
.
J Clin Epidemiol
.
2008
Jan
;
61
(
1
):
64
75
.
[PubMed]
0895-4356
29.
Puhan
MA
,
Schünemann
HJ
,
Murad
MH
,
Li
T
,
Brignardello-Petersen
R
,
Singh
JA
, et al;
GRADE Working Group
.
A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
.
BMJ
.
2014
Sep
;
349
sep24 5
:
g5630
.
[PubMed]
0959-8138
30.
IntHout
J
,
Ioannidis
JP
,
Rovers
MM
,
Goeman
JJ
.
Plea for routinely presenting prediction intervals in meta-analysis
.
BMJ Open
.
2016
Jul
;
6
(
7
):
e010247
.
[PubMed]
2044-6055
31.
Holt
RIG
,
Gossage-worrall
R
,
Hind
D
,
Bradburn
MJ
,
Mccrone
P
,
Morris
T
, et al
Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE) : randomised controlled trial.
2018
;1–11.
32.
McKibbin
CL
,
Patterson
TL
,
Norman
G
,
Patrick
K
,
Jin
H
,
Roesch
S
, et al
A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial
.
Schizophr Res
.
2006
Sep
;
86
(
1-3
):
36
44
.
[PubMed]
0920-9964
33.
Kwon
JS
,
Choi
JS
,
Bahk
WM
,
Yoon Kim
C
,
Hyung Kim
C
,
Chul Shin
Y
, et al
Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial
.
J Clin Psychiatry
.
2006
Apr
;
67
(
4
):
547
53
.
[PubMed]
0160-6689
34.
Scheewe
TW
,
Backx
FJ
,
Takken
T
,
Jörg
F
,
van Strater
AC
,
Kroes
AG
, et al
Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial
.
Acta Psychiatr Scand
.
2013
Jun
;
127
(
6
):
464
73
.
[PubMed]
0001-690X
35.
Evans
S
,
Newton
R
,
Higgins
S
.
Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial
.
Aust N Z J Psychiatry
.
2005
Jun
;
39
(
6
):
479
86
.
[PubMed]
0004-8674
36.
Goldberg
RW
,
Reeves
G
,
Tapscott
S
,
Medoff
D
,
Dickerson
F
,
Goldberg
AP
, et al
“MOVE!” Outcomes of a weight loss program modified for veterans with serious mental illness
.
Psychiatr Serv
.
2013
Aug
;
64
(
8
):
737
44
.
[PubMed]
1075-2730
37.
Khazaal
Y
,
Fresard
E
,
Rabia
S
,
Chatton
A
,
Rothen
S
,
Pomini
V
, et al
Cognitive behavioural therapy for weight gain associated with antipsychotic drugs
.
Schizophr Res
.
2007
Mar
;
91
(
1-3
):
169
77
.
[PubMed]
0920-9964
38.
Lee
H
,
Kane
I
,
Brar
J
,
Sereika
S
.
Telephone-delivered physical activity intervention for individuals with serious mental illness: a feasibility study
.
J Am Psychiatr Nurses Assoc
.
2014
Nov-Dec
;
20
(
6
):
389
97
.
[PubMed]
1078-3903
39.
Methapatara
W
,
Srisurapanont
M
.
Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: a 12-week, randomized, controlled trial
.
Psychiatry Clin Neurosci
.
2011
Jun
;
65
(
4
):
374
80
.
[PubMed]
1323-1316
40.
Kilbourne
AM
,
Goodrich
DE
,
Lai
Z
,
Clogston
J
,
Waxmonsky
J
,
Bauer
MS
.
Life Goals Collaborative Care for patients with bipolar disorder and cardiovascular disease risk
.
Psychiatr Serv
.
2012
Dec
;
63
(
12
):
1234
8
.
[PubMed]
1075-2730
41.
Kilbourne
AM
,
Goodrich
DE
,
Lai
Z
,
Post
EP
,
Schumacher
K
,
Nord
KM
, et al
Randomized controlled trial to assess reduction of cardiovascular disease risk in patients with bipolar disorder: the Self-Management Addressing Heart Risk Trial (SMAHRT)
.
J Clin Psychiatry
.
2013
Jul
;
74
(
7
):
e655
62
.
[PubMed]
0160-6689
42.
Gaughran
F
,
Stahl
D
,
Ismail
K
,
Greenwood
K
,
Atakan
Z
,
Gardner-sood
P
, et al
Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT) .
2017
;1–14.
43.
Kilbourne
AM
,
Barbaresso
MM
,
Lai
Z
,
Nord
KM
,
Bramlet
M
,
Goodrich
DE
, et al
Improving Physical Health in Patients With Chronic Mental Disorders: Twelve-Month Results From a Randomized Controlled Collaborative Care Trial
.
J Clin Psychiatry
.
2016
Oct
.
[PubMed]
0160-6689
44.
Brar
JS
,
Ganguli
R
,
Pandina
G
,
Turkoz
I
,
Berry
S
,
Mahmoud
R
.
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder
.
J Clin Psychiatry
.
2005
Feb
;
66
(
2
):
205
12
.
[PubMed]
0160-6689
45.
Littrell
KH
,
Hilligoss
NM
,
Kirshner
CD
,
Petty
RG
,
Johnson
CG
.
The effects of an educational intervention on antipsychotic-induced weight gain
.
J Nurs Scholarsh
.
2003
;
35
(
3
):
237
41
.
[PubMed]
1527-6546
46.
Cordes
J
,
Thünker
J
,
Regenbrecht
G
,
Zielasek
J
,
Correll
CU
,
Schmidt-Kraepelin
C
, et al
Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial
.
World J Biol Psychiatry
.
2014
Apr
;
15
(
3
):
229
41
.
[PubMed]
1562-2975
47.
Lovell
K
,
Wearden
A
,
Bradshaw
T
,
Tomenson
B
,
Pedley
R
,
Davies
LM
, et al
An exploratory randomized controlled study of a healthy living intervention in early intervention services for psychosis: the INTERvention to encourage ACTivity, improve diet, and reduce weight gain (INTERACT) study
.
J Clin Psychiatry
.
2014
May
;
75
(
5
):
498
505
.
[PubMed]
0160-6689
48.
Usher
K
,
Park
T
,
Foster
K
,
Buettner
P
.
A randomized controlled trial undertaken to test a nurse-led weight management and exercise intervention designed for people with serious mental illness who take second generation antipsychotics
.
J Adv Nurs
.
2013
Jul
;
69
(
7
):
1539
48
.
[PubMed]
0309-2402
49.
Bartels
SJ
,
Pratt
SI
,
Aschbrenner
KA
,
Barre
LK
,
Jue
K
,
Wolfe
RS
, et al
Clinically significant improved fitness and weight loss among overweight persons with serious mental illness
.
Psychiatr Serv
.
2013
Aug
;
64
(
8
):
729
36
.
[PubMed]
1075-2730
50.
Attux
C
,
Martini
LC
,
Elkis
H
,
Tamai
S
,
Freirias
A
,
Camargo
M
, et al
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
.
BMC Psychiatry
.
2013
Feb
;
13
(
1
):
60
.
[PubMed]
1471-244X
51.
Weber
M
,
Wyne
K
.
A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics
.
Schizophr Res
.
2006
Mar
;
83
(
1
):
95
101
.
[PubMed]
0920-9964
52.
Bartels
SJ
,
Pratt
SI
,
Aschbrenner
KA
,
Barre
LK
,
Naslund
JA
,
Wolfe
R
, et al
Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes
.
Am J Psychiatry
.
2015
Apr
;
172
(
4
):
344
52
.
[PubMed]
0002-953X
53.
Daumit
GL
,
Dickerson
FB
,
Wang
NY
,
Dalcin
A
,
Jerome
GJ
,
Anderson
CA
, et al
A behavioral weight-loss intervention in persons with serious mental illness
.
N Engl J Med
.
2013
Apr
;
368
(
17
):
1594
602
.
[PubMed]
0028-4793
54.
Green
CA
,
Yarborough
BJ
,
Leo
MC
,
Yarborough
MT
,
Stumbo
SP
,
Janoff
SL
, et al
The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial
.
Am J Psychiatry
.
2015
Jan
;
172
(
1
):
71
81
.
[PubMed]
0002-953X
55.
Iglesias-García
C
,
Toimil-Iglesias
A
,
Alonso-Villa
MJ
.
Pilot study of the efficacy of an educational programme to reduce weight, on overweight and obese patients with chronic stable schizophrenia
.
J Psychiatr Ment Health Nurs
.
2010
Nov
;
17
(
9
):
849
51
.
[PubMed]
1351-0126
56.
Ratliff
JC
,
Palmese
LB
,
Tonizzo
KM
,
Chwastiak
L
,
Tek
C
.
Contingency management for the treatment of antipsychotic-induced weight gain: a randomized controlled pilot study
.
Obes Facts
.
2012
;
5
(
6
):
919
27
.
[PubMed]
1662-4025
57.
Osborn
DP
,
Nazareth
I
,
Wright
CA
,
King
MB
.
Impact of a nurse-led intervention to improve screening for cardiovascular risk factors in people with severe mental illnesses. Phase-two cluster randomised feasibility trial of community mental health teams
.
BMC Health Serv Res
.
2010
Mar
;
10
(
1
):
61
.
[PubMed]
1472-6963
58.
Skrinar
GS
,
Huxley
NA
,
Hutchinson
DS
,
Menninger
E
,
Glew
P
.
The role of a fitness intervention on people with serious psychiatric disabilities
.
Psychiatr Rehabil J
.
2005
;
29
(
2
):
122
7
.
[PubMed]
1095-158X
59.
Masa-Font
R
,
Fernández-San-Martín
MI
,
Martín López
LM
,
Alba Muñoz
AM
,
Oller Canet
S
,
Martín Royo
J
, et al
The effectiveness of a program of physical activity and diet to modify cardiovascular risk factors in patients with severe mental illness after 3-month follow-up: CAPiCOR randomized clinical trial
.
Eur Psychiatry
.
2015
Nov
;
30
(
8
):
1028
36
.
[PubMed]
0924-9338
60.
Battaglia
G
,
Alesi
M
,
Inguglia
M
,
Roccella
M
,
Caramazza
G
,
Bellafiore
M
, et al
Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia
.
Neuropsychiatr Dis Treat
.
2013
;
9
:
595
603
.
[PubMed]
1176-6328
61.
Scocco
P
,
Longo
R
,
Caon
F
.
Weight change in treatment with olanzapine and a psychoeducational approach
.
Eat Behav
.
2006
May
;
7
(
2
):
115
24
.
[PubMed]
1471-0153
62.
Mauri
M
,
Simoncini
M
,
Castrogiovanni
S
,
Iovieno
N
,
Cecconi
D
,
Dell’Agnello
G
, et al
A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine
.
Pharmacopsychiatry
.
2008
Jan
;
41
(
1
):
17
23
.
[PubMed]
0176-3679
63.
Beebe
LH
,
Smith
K
,
Burk
R
,
Dessieux
O
,
Velligan
D
,
Tavakoli
A
, et al
Effect of a motivational group intervention upon exercise self efficacy and outcome expectations for exercise in Schizophrenia Spectrum Disorders (SSDs)
.
J Am Psychiatr Nurses Assoc
.
2010
Apr
;
16
(
2
):
105
13
.
[PubMed]
1078-3903
64.
Milano
W
,
Grillo
F
,
Del Mastro
A
,
De Rosa
M
,
Sanseverino
B
,
Petrella
C
, et al
Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study
.
Adv Ther
.
2007
Jan-Feb
;
24
(
1
):
123
34
.
[PubMed]
0741-238X
65.
Forsberg
KA
,
Björkman
T
,
Sandman
PO
,
Sandlund
M
,
Bjorkman
T
,
Sandman
PO
, et al
Physical health—a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and their staff
.
Nord J Psychiatry
.
2008
;
62
(
6
):
486
95
.
[PubMed]
0803-9488
66.
Marzolini
S
,
Jensen
B
,
Melville
P
.
Feasibility and effects of a group-based resistance and aerobic exercise program for individuals with severe schizophrenia : A multidisciplinary approach.
2009
;2:29–36.
67.
Gillhoff
K
,
Gaab
J
,
Emini
L
,
Maroni
C
,
Tholuck
J
,
Greil
W
.
Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial
.
Prim Care Companion J Clin Psychiatry
.
2010
;
12
(
5
):
PCC.09m00906
.
[PubMed]
1523-5998
68.
Wu
MK
,
Wang
CK
,
Bai
YM
,
Huang
CY
,
Lee
SD
.
Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program
.
Psychiatr Serv
.
2007
Apr
;
58
(
4
):
544
50
.
[PubMed]
1075-2730
69.
Wu
RR
,
Zhao
JP
,
Jin
H
,
Shao
P
,
Fang
MS
,
Guo
XF
, et al
Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial
.
JAMA
.
2008
Jan
;
299
(
2
):
185
93
.
[PubMed]
0098-7484
70.
Alvarez-Jiménez
M
,
González-Blanch
C
,
Vázquez-Barquero
JL
,
Pérez-Iglesias
R
,
Martínez-García
O
,
Pérez-Pardal
T
, et al
Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial
.
J Clin Psychiatry
.
2006
Aug
;
67
(
8
):
1253
60
.
[PubMed]
0160-6689
71.
Fanelli
D
,
Costas
R
,
Larivi
V
.
Misconduct Policies
.
Academic Culture and Career Stage, Not Gender or Pressures to Publish, Affect Scientific Integrity
;
2015
. pp.
1
18
.
72.
Dayabandara
M
,
Hanwella
R
,
Ratnatunga
S
,
Seneviratne
S
,
Suraweera
C
,
de Silva
VA
. Antipsychotic-associated weight gain: Management strategies and impact on treatment adherence. Vol. 13, Neuropsychiatric Disease and Treatment. Dove Medical Press Ltd.;
2017
. p. 2231–41.
73.
Carvalho
AF
,
Sharma
MS
,
Brunoni
AR
,
Vieta
E
,
Fava
GA
.
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
.
Psychother Psychosom
.
2016
;
85
(
5
):
270
88
.
[PubMed]
0033-3190
74.
Carrière
K
,
Khoury
B
,
Günak
MM
,
Knäuper
B
.
Mindfulness-based interventions for weight loss: a systematic review and meta-analysis.
Vol. 19, Obesity Reviews. Blackwell Publishing Ltd;
2018
. p. 164–77.
75.
Burgess
E
,
Hassmén
P
,
Welvaert
M
,
Pumpa
KL
.
Behavioural treatment strategies improve adherence to lifestyle intervention programmes in adults with obesity: a systematic review and meta-analysis
.
Clin Obes
.
2017
Apr
;
7
(
2
):
105
14
.
[PubMed]
1758-8103
76.
Guidi
J
,
Brakemeier
EL
,
Bockting
CL
,
Cosci
F
,
Cuijpers
P
,
Jarrett
RB
, et al
Methodological Recommendations for Trials of Psychological Interventions
.
Psychother Psychosom
.
2018
;
87
(
5
):
276
84
.
[PubMed]
0033-3190
77.
Vancampfort
D
,
Firth
J
,
Correll
CU
,
Solmi
M
,
Siskind
D
,
Hert
M
De
, et al
The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia : a meta-review of meta-analyses of randomized controlled trials.
2019
;(February):53–66.
78.
Ebrahim
S
,
Taylor
F
,
Ward
K
,
Beswick
A
,
Burke
M
,
Davey Smith
G
.
Multiple risk factor interventions for primary prevention of coronary heart disease
.
Cochrane Database Syst Rev
.
2011
Jan
;(
1
):
CD001561
.
[PubMed]
1469-493X
79.
Jørgensen
T
,
Kart
R
,
Toft
U
,
Aadahl
M
,
Glümer
C
,
Pisinger
C
. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population : Inter99 randomised trial.
2014
;3617(June):1–11.
80.
Wing
RR
,
Bolin
P
,
Brancati
FL
,
Bray
GA
,
Clark
JM
,
Coday
M
, et al;
Look AHEAD Research Group
.
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
.
N Engl J Med
.
2013
Jul
;
369
(
2
):
145
54
.
[PubMed]
0028-4793
81.
Ioannidis
JP
.
Contradicted and initially stronger effects in highly cited clinical research
.
JAMA
.
2005
Jul
;
294
(
2
):
218
28
.
[PubMed]
0098-7484
82.
Kirsch
I
,
Moncrieff
J
.
Clinical trials and the response rate illusion
.
Contemp Clin Trials
.
2007
Jul
;
28
(
4
):
348
51
.
[PubMed]
1551-7144
83.
Puhl
RM
,
Heuer
CA
.
Obesity stigma: important considerations for public health
.
Am J Public Health
.
2010
Jun
;
100
(
6
):
1019
28
.
[PubMed]
0090-0036
84.
Janz
K
,
Becker
MH
.
The Health Belief Model : A Decade Later.
1984
;1–47.
85.
Barr
B
,
Higgerson
J
,
Whitehead
M
.
Investigating the impact of the English health inequalities strategy: time trend analysis
.
BMJ
.
2017
Jul
;
358
:
j3310
.
[PubMed]
0959-8138
86.
Marmot
M
,
Allen
J
,
Bell
R
,
Bloomer
E
,
Goldblatt
P
,
Determinants
S
, et al
Review WHO European review of social determinants of health and
.
Lancet
.
2012
;
380
(
9846
):
1011
29
.
[PubMed]
0140-6736
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.